0001179110-15-007644.txt : 20150512
0001179110-15-007644.hdr.sgml : 20150512
20150512172919
ACCESSION NUMBER: 0001179110-15-007644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150508
FILED AS OF DATE: 20150512
DATE AS OF CHANGE: 20150512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PUHY DOROTHY E
CENTRAL INDEX KEY: 0001200493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 15855614
MAIL ADDRESS:
STREET 1: DANA FARBER CANCER INSTITUTE
STREET 2: 44 BINNEY STREET, RM. D1632
CITY: BOSTON
STATE: MA
ZIP: 02115
4
1
edgar.xml
FORM 4 -
X0306
4
2015-05-08
0
0000815094
ABIOMED INC
ABMD
0001200493
PUHY DOROTHY E
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS
MA
01923
1
0
0
0
Common Stock, $0.01 par value
2015-05-08
4
S
0
864
64.1598
D
68940
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
971
65.1291
D
67969
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
510
66.3304
D
67459
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
1301
67.3336
D
66158
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
737
67.8776
D
65421
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
174
69.0306
D
65247
D
Common Stock, $0.01 par value
2015-05-08
4
S
0
19
69.8099
D
65228
D
Stock Option (right to buy)
13.21
2007-08-08
2016-08-09
Common Stock
8000
8000
D
Stock option (right to buy)
12.69
2008-08-13
2017-08-08
Common Stock
8000
8000
D
Stock Option (right to buy)
18.63
2009-08-12
2018-08-13
Common Stock
13500
13500
D
Stock Option (right to buy)
7.67
2010-08-11
2019-08-12
Common Stock
13500
13500
D
Stock Option (right to buy)
9.99
2011-08-10
2020-08-11
Common Stock
13500
13500
D
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This option becomes exerciseable in full on the date set forth in Table II, Column 6.
/s/ Stephen C. McEvoy (by power of attorney)
2015-05-12
EX-24
2
ex24puhy.txt
LIMITED POWER OF ATTORNEY
The undersigned does hereby appoint each of
Stephen McEvoy, Robert Bowen, Ian McLeod, and Loretta
Wedge, signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as a
director or officer of ABIOMED, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall
be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this power of attorney has
been executed as of the 3rd day of July, 2009 and
shall remain in full force and effect until withdrawn
by the undersigned in writing.
Signature: /s/ Dorothy E. Puhy
Print Name: Dorothy E. Puhy
- 2 -